RFL (Rafael Holdings) Research & Development: $24.41 Mil (TTM As of Apr. 2026)


RFL Rafael Holdings Inc RFL
48 GF Score
Price $2.70
GF Value $1.35
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Rafael Holdings Research & Development?

Rafael Holdings RFL -0.37% 48 Research & Development is $24.41 Mil as of Apr. 2026. GuruFocus rates RFL with a GF Score™ of 48/100 and a GF Value™ of $1.35 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Rafael Holdings's Research & Development for the three months ended in Apr. 2026 was $4.85 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 was $24.41 Mil.

Rafael Holdings  (NYSE:RFL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Rafael Holdings Research & Development Related Terms

Rafael Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Rafael Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rafael Holdings Research & Development Chart

Rafael Holdings Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.91 8.74 6.31 94.03 12.82

Rafael Holdings Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 7.55 7.48 4.53 4.85
RFL
48GF Score
Rafael Holdings Inc RFL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rafael Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $24.41 Mil mean?
Rafael Holdings (RFL) has a Research & Development of $24.41 Mil as of Apr. 2026. Research and development expense is the total cost for research and development activities. View historical data on Rafael Holdings and its competitors.
Is Rafael Holdings' Research & Development too high?
Rafael Holdings' current Research & Development is $24.41 Mil. Overall, Rafael Holdings has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rafael Holdings' Research & Development compare to ASPS and MAYS?
Rafael Holdings' Research & Development of $24.41 Mil can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Real Estate company?
A good Research & Development depends on the Real Estate industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Rafael Holdings and its competitors. Rafael Holdings's current Research & Development is $24.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rafael Holdings stock overvalued right now?
Based on GuruFocus' analysis, Rafael Holdings (RFL) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.35, compared to a current price of $2.70 — trading 100% above its estimated fair value. The current Research & Development is $24.41 Mil. Rafael Holdings' overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Rafael Holdings (RFL), the current Research & Development is $24.41 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rafael Holdings (RFL) Overvalued in 2026?

Based on GuruFocus' analysis, Rafael Holdings stock appears to be overvalued. The current stock price of $2.70 is trading 100% above its estimated GF Value™ of $1.35. GuruFocus considers Rafael Holdings to be Significantly Overvalued.

Key valuation signals for RFL:

  • Research & Development: $24.41 Mil
  • GF Value™: $1.35 vs. price of $2.70 (100% above fair value)
  • GF Score™: 48/100 with 8 warning signs

No single metric tells the full story. See the RFL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rafael Holdings Business Description

Address 520 Broad Street, Newark, NJ, USA, 07102
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
48GF Score

Get the complete analysis for RFL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.70
Price
$1.35
GF Value